Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2019 - 2021)

IDEAYA Biosciences (IDYA) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $6000.0 as the latest value for Q3 2021.

  • Quarterly Other Non-Current Liabilities fell 50.0% to $6000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Sep 2021, down 50.0% year-over-year, with the annual reading at $12000.0 for FY2020, 64.71% down from the prior year.
  • Other Non-Current Liabilities hit $6000.0 in Q3 2021 for IDEAYA Biosciences, roughly flat from $6000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $60000.0 in Q2 2019 to a low of $6000.0 in Q1 2021.
  • Historically, Other Non-Current Liabilities has averaged $22500.0 across 3 years, with a median of $14000.0 in 2020.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 76.92% in 2020 and later crashed 50.0% in 2021.
  • Year by year, Other Non-Current Liabilities stood at $34000.0 in 2019, then crashed by 64.71% to $12000.0 in 2020, then plummeted by 50.0% to $6000.0 in 2021.
  • Business Quant data shows Other Non-Current Liabilities for IDYA at $6000.0 in Q3 2021, $6000.0 in Q2 2021, and $6000.0 in Q1 2021.